TagsNemolizumab

Tag: nemolizumab

Healthcare

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis

Ravindra Soni - March 30, 2026 0

Corporate

AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs

Ravindra Soni - March 24, 2026 0

Healthcare

Galderma's Nemluvio® (nemolizumab) Demonstrates Long-Term Disease Control in Prurigo Nodularis up to Three Years

Ravindra Soni - February 28, 2026 0

Most Read

INOX India Q2 FY27 revenue rises 26.6% to ₹467 crore, order backlog hits record

November 3, 2026

Doodhvale Farms wins Emerging D2C Dairy Protein Brand at The India Collective

November 3, 2026

NSN Mohan elected first Indian SKÅL International World President for 2027

November 3, 2026

Wintermar Offshore Q3 profit surges 67.6% on higher vessel margins

November 3, 2026